Personal tools

Difference between revisions of "FF:0000350"

From FANTOM5_SSTAR

Jump to: navigation, search
(Created page with "{{F5terms |id=FF:0000350 |name=experimentally modified sample |namespace=FANTOM5 |def= |xref= |is_a=FF:0000001 |synonym= |comment= |alt_id= |disjoint_from= |union_o...")
 
 
(One intermediate revision by the same user not shown)
Line 1: Line 1:
 
{{F5terms
 
{{F5terms
|id=FF:0000350
+
|alt_id=
|name=experimentally modified sample
 
|namespace=FANTOM5
 
|def=
 
|xref=
 
|is_a=FF:0000001
 
|synonym=
 
 
|comment=
 
|comment=
|alt_id=
 
|disjoint_from=
 
|union_of=
 
 
|created_by=tmeehan
 
|created_by=tmeehan
|obo_creation_date=2011-04-29T10:41:03Z
+
|def=
|subset=
 
|adjacent_to=
 
 
|derives_from=
 
|derives_from=
 
|develops_from=
 
|develops_from=
 +
|disjoint_from=
 
|has_quality=
 
|has_quality=
 +
|id=FF:0000350
 +
|is_a=FF:0000001
 +
|is_obsolete=
 
|located_in=
 
|located_in=
 +
|name=experimentally modified sample
 +
|namespace=FANTOM5
 +
|obo_creation_date=2011-04-29T10:41:03Z
 
|part_of=
 
|part_of=
 +
|preceded_by=
 
|property_value=
 
|property_value=
|is_obsolete=
+
|subset=
|preceded_by=
+
|synonym=
 +
|union_of=
 +
|xref=
 
}}
 
}}

Latest revision as of 01:39, 12 September 2014

outline

  • id: FF:0000350
  • name: experimentally modified sample
  • namespace: FANTOM5
  • created_by: tmeehan
  • creation_date: 29 April 2011 10:41:03
  • CAGEd oPOSSUM: NA

Ontology association

Parents

is_a:FF:0000001(sample)

Children

is a:FF:0000408 (cellular fractionation sample),FF:0000410 (human Lymphatic Endothelial cells 0min after VEGFC treatment sample),FF:0000411 (human Lymphatic Endothelial cells 15min after VEGFC treatment sample),FF:0000412 (human Lymphatic Endothelial cells 30min after VEGFC treatment sample),FF:0000413 (human Lymphatic Endothelial cells 45min after VEGFC treatment sample),FF:0000414 (human Lymphatic Endothelial cells 1hr after VEGFC treatment sample),FF:0000415 (human Lymphatic Endothelial cells 80min after VEGFC treatment sample),FF:0000416 (human Lymphatic Endothelial cells 100min after VEGFC treatment sample),FF:0000417 (human Lymphatic Endothelial cells 2h after VEGFC treatment sample),FF:0000418 (human Lymphatic Endothelial cells 2.5h after VEGFC treatment sample),FF:0000419 (human Lymphatic Endothelial cells 3h after VEGFC treatment sample),FF:0000420 (human Lymphatic Endothelial cells 3.5h after VEGFC treatment sample),FF:0000421 (human Lymphatic Endothelial cells 4h after VEGFC treatment sample),FF:0000422 (human Lymphatic Endothelial cells 5h after VEGFC treatment sample),FF:0000423 (human Lymphatic Endothelial cells 6h after VEGFC treatment sample),FF:0000424 (human Lymphatic Endothelial cells 7h after VEGFC treatment sample),FF:0000425 (human Lymphatic Endothelial cells 8h after VEGFC treatment sample),FF:0000426 (human MCF7 breast cancer cell line 0min after EGF1 treatment sample),FF:0000427 (human MCF7 breast cancer cell line 15min after EGF1 treatment sample),FF:0000428 (human MCF7 breast cancer cell line 30min after EGF1 treatment sample),FF:0000429 (human MCF7 breast cancer cell line 45min after EGF1 treatment sample),FF:0000430 (human MCF7 breast cancer cell line 1hr after EGF1 treatment sample),FF:0000431 (human MCF7 breast cancer cell line 80min after EGF1 treatment sample),FF:0000432 (human MCF7 breast cancer cell line 100min after EGF1 treatment sample),FF:0000433 (human MCF7 breast cancer cell line 2h after EGF1 treatment sample),FF:0000434 (human MCF7 breast cancer cell line 2.5h after EGF1 treatment sample),FF:0000435 (human MCF7 breast cancer cell line 3h after EGF1 treatment sample),FF:0000436 (human MCF7 breast cancer cell line 3.5h after EGF1 treatment sample),FF:0000437 (human MCF7 breast cancer cell line 4h after EGF1 treatment sample),FF:0000438 (human MCF7 breast cancer cell line 5h after EGF1 treatment sample),FF:0000439 (human MCF7 breast cancer cell line 6h after EGF1 treatment sample),FF:0000440 (human MCF7 breast cancer cell line 7h after EGF1 treatment sample),FF:0000441 (human MCF7 breast cancer cell line 8h after EGF1 treatment sample),FF:0000442 (MCF7 breast cancer cell line 0min after HRG treatment),FF:0000443 (human MCF7 breast cancer cell line 15min after HRG treatment sample),FF:0000444 (human MCF7 breast cancer cell line 30min after HRG treatment sample),FF:0000445 (human MCF7 breast cancer cell line 45min after HRG treatment sample),FF:0000446 (human MCF7 breast cancer cell line 1hr after HRG treatment sample),FF:0000447 (human MCF7 breast cancer cell line 80min after HRG treatment sample),FF:0000448 (human MCF7 breast cancer cell line 100min after HRG treatment sample),FF:0000449 (human MCF7 breast cancer cell line 2h after HRG treatment sample),FF:0000450 (human MCF7 breast cancer cell line 2.5h after HRG treatment sample),FF:0000451 (human MCF7 breast cancer cell line 3h after HRG treatment sample),FF:0000452 (human MCF7 breast cancer cell line 3.5h after HRG treatment sample),FF:0000453 (human MCF7 breast cancer cell line 4h after HRG treatment sample),FF:0000454 (human MCF7 breast cancer cell line 5h after HRG treatment sample),FF:0000455 (human MCF7 breast cancer cell line 6h after HRG treatment sample),FF:0000456 (human MCF7 breast cancer cell line 7h after HRG treatment sample),FF:0000457 (human MCF7 breast cancer cell line 8h after HRG treatment sample),FF:0000458 (mouse ST2 Mesenchymal stem cells, cells 15 min after adipogenic induction sample)... further results

FF Samples

Human

... further results